RecruitingEarly Phase 1NCT07228286
REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study
Sponsor
Samuel Snider, MD
Enrollment
2 participants
Start Date
Nov 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The RE-CONNECT study is an early feasibility study to establish the safety, feasibility, and efficacy of two central thalamic deep brain stimulation targets in patients with chronic disorders of consciousness.
Eligibility
Min Age: 18 YearsMax Age: 55 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Deep brain stimulation (DBS) electrode implantation for people with disorders of consciousness. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 55 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDeep brain stimulation (DBS) electrode implantation
DBS electrodes implanted to two targets in each thalamus.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07228286
Related Trials
Spontaneous Eye Blinking in Disorders of Consciousness
NCT063230318 locations
China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）
NCT059753981 location
Assessment of Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Disorders of Consciousness
NCT076942581 location
fNIRS for Disorders of Consciousness
NCT074853611 location
Recovery Trajectory for Coma and Disorders of Consciousness
NCT076140741 location